Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
181-195 of 622
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsultTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Identifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Clinician's RoundtableIdentifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
Rising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
Clinician's RoundtableRising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular HealthOvercoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
- advertisement
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular HealthEvaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Navigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Clinician's RoundtableNavigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Rewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
FCDC Action CenterRewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
Combination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
FCDC Action CenterCombination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
- advertisement
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
FCDC Action CenterImproving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living RheumDelaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings











































